This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why

Key PointsNew York City-based Armistice Capital sold 1,458,192 shares of PTC Therapeutics for an estimated $30.2 million in the third quarter.At quarter-end, Armistice reporting holding a total of nearly 3.3 million PTC Therapeutics shares valued at $201.1 million.PTC Therapeutics remains the fund’s largest holding at 2.5% of AUM.These 10 stocks could mint the next wave of millionaires › As reported in an SEC filing on Friday, New York City-base…